Winthrop Advisory Group’s Sangamo Therapeutics SGMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-10,000
| Closed | -$8.66K | – | 169 |
|
|
2024
Q3 | $8.66K | Hold |
10,000
| – | – | ﹤0.01% | 152 |
|
|
2024
Q2 | $3.58K | Hold |
10,000
| – | – | ﹤0.01% | 144 |
|
|
2024
Q1 | $6.7K | Hold |
10,000
| – | – | ﹤0.01% | 141 |
|
|
2023
Q4 | $5.43K | Hold |
10,000
| – | – | ﹤0.01% | 139 |
|
|
2023
Q3 | $6K | Hold |
10,000
| – | – | ﹤0.01% | 126 |
|
|
2023
Q2 | $13K | Hold |
10,000
| – | – | ﹤0.01% | 132 |
|
|
2023
Q1 | $17.6K | Hold |
10,000
| – | – | ﹤0.01% | 128 |
|
|
2022
Q4 | $31.4K | Hold |
10,000
| – | – | 0.01% | 121 |
|
|
2022
Q3 | $49K | Hold |
10,000
| – | – | 0.01% | 114 |
|
|
2022
Q2 | $41K | Hold |
10,000
| – | – | 0.01% | 119 |
|
|
2022
Q1 | $58K | Hold |
10,000
| – | – | 0.01% | 136 |
|
|
2021
Q4 | $75K | Hold |
10,000
| – | – | 0.02% | 139 |
|
|
2021
Q3 | $90K | Sell |
10,000
-50
| -0.5% | -$450 | 0.02% | 138 |
|
|
2021
Q2 | $120K | Buy |
10,050
+50
| +0.5% | +$597 | 0.03% | 132 |
|
|
2021
Q1 | $125K | Buy |
+10,000
| New | +$125K | 0.03% | 132 |
|